Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 727 | 0 | 526 |
| Operating Income | -727 | N/A | -526 |
| Interest Expense | 0 | 0 | 135 |
| Other Income | -743 | 0 | -852 |
| Pre-tax Income | -1,470 | 0 | -1,514 |
| Income Tax | 2 | N/A | N/A |
| Net Income Continuous | -1,472 | N/A | -1,514 |
| Net Income | $-1,472 | $N/A | $-1,514 |
| EPS Basic Total Ops | -0.55 | N/A | -0.57 |
| EPS Basic Continuous Ops | -0.55 | N/A | -0.57 |
| EPS Diluted Total Ops | -0.55 | N/A | -0.57 |
| EPS Diluted Continuous Ops | -0.55 | N/A | -0.57 |
| EBITDA(a) | $252 | $N/A | $-526 |